Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries.
We hypothesized that in salt-dependent forms of hypertension, endogenous ouabain acts on arterial smooth muscle to cause enhanced vasoconstriction. Here, we tested for the involvement of the arterial endothelium and perivascular sympathetic nerve terminals in ouabain-induced vasoconstriction. Segments of rat mesenteric or renal interlobar arteries were pressurized to 70 mmHg at 37 degrees C and exposed to ouabain (10(-11)-10(-7) M). Removal of the endothelium enhanced ouabain-induced vasoconstriction by as much as twofold (at an ouabain concentration of 10(-9) M). A component of the ouabain-induced vasoconstriction is due to the enhanced spontaneous release of norepinephrine (NE) from nerve terminals in the arterial wall. The alpha(1)-adrenoceptor blocker prazosin (10(-6) M) decreased ouabain-induced vasoconstrictions by as much as 50%. However, neither the contraction induced by sympathetic nerve activity (SNA) nor the NE release evoked by SNA (measured directly by carbon fiber amperometry) was increased by ouabain (<10(-7) M). Nevertheless, the converse case was true: after brief bursts of SNA, vasoconstrictor responses to ouabain were transiently increased (1.75-fold). This effect may be mediated by neuropeptide Y and Y(1) receptors on smooth muscle. In arteries lacking the endothelium and exposed to prazosin, ouabain (10(-11) M and greater) caused vasoconstriction, indicating a direct effect of very "low" concentrations of ouabain on arterial smooth muscle. In conclusion, in intact arteries, the endothelium opposes ouabain (10(-11)-10(-7)M)-induced vasoconstriction, which is caused by both enhanced spontaneous NE release and direct effects on smooth muscle. Ouabain (<10(-7)M) does not enhance SNA-mediated contractions, but SNA enhances ouabain-induced contractions. The effects of endogenous ouabain may be accentuated in forms of hypertension that involve sympathetic nerve hyperactivity and/or endothelial dysfunction.
Raina
Hema
H
Dept. of Physiology, Univ. of Maryland School of Medicine, Baltimore, MD 21201, USA.
Zhang
Qingli
Q
Rhee
Albert Y
AY
Pallone
Thomas L
TL
Wier
W Gil
WG
D000818:Animals; D004305:Dose-Response Relationship, Drug; D055724:Electrophysiological Phenomena; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D008638:Mesenteric Arteries / Q000187:drug effects / Q000502:physiology*; D023421:Models, Animal; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D009478:Neuropeptide Y / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012077:Renal Artery / Q000187:drug effects / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000502:physiology*; D014661:Vasoconstriction / Q000187:drug effects* / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D009478:Neuropeptide Y; D018377:Neurotransmitter Agents; D014662:Vasoconstrictor Agents; D010042:Ouabain; D009638:Norepinephrine
J Pharmacol Sci. 2003 Jun;92(2):84-92
12832835
J Hypertens. 2003 Aug;21(8):1475-81
12872040
Rev Physiol Biochem Pharmacol. 2003;150:91-139
12884052
J Vasc Res. 2001 Jan-Feb;38(1):1-12
11173989
Acta Physiol Scand. 1984 Mar;120(3):477-9
6547562
Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6259-63
1648735
J Physiol. 2007 Jul 15;582(Pt 2):745-54
17510179
Br J Pharmacol. 1997 Mar;120(5):769-76
9138680
Clin Exp Hypertens. 1998 Jul-Aug;20(5-6):581-91
9682914
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2188-97
18835922
Am J Physiol Heart Circ Physiol. 2000 Aug;279(2):H679-91
10924067
Am J Physiol. 1993 Mar;264(3 Pt 1):E413-9
8460688
Neurochem Int. 1999 Dec;35(6):439-45
10524711
Exp Physiol. 2009 Jan;94(1):31-7
18931047
J Physiol. 2005 Nov 15;569(Pt 1):243-56
16166162
Circ Res. 2007 Jan 5;100(1):121-9
17158339
Circ Res. 2002 Sep 20;91(6):454-6
12242262
Circulation. 1992 Aug;86(2):420-5
1322253
Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R553-9
16467503
Endocrinology. 1994 Aug;135(2):794-7
8033829
Am J Physiol Renal Physiol. 2005 Oct;289(4):F891-901
15914781
Physiol Rev. 1990 Oct;70(4):963-85
1977182
J Hypertens. 1998 Dec;16(12 Pt 2):1953-8
9886882
J Hypertens. 2007 Sep;25(9):1834-44
17762648
Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1109-17
16603700
Am J Physiol Heart Circ Physiol. 2009 Sep;297(3):H1140-50
19617413
J Neurochem. 2010 Jan;112(2):340-55
19891736
Hypertens Res. 2000 Sep;23 Suppl:S77-85
11016824
Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R509-13
16467497
Am J Physiol Cell Physiol. 2007 Aug;293(2):C509-36
17494630
Am J Hypertens. 1997 Aug;10(8):929-35
9270089
J Physiol. 1965 Mar;177:21-30
14296957
J Physiol. 2008 Mar 15;586(6):1669-81
18218677
J Neurosci. 2001 Dec 15;21(24):9598-607
11739570
Br J Pharmacol. 1999 Sep;128(1):174-80
10498849
Hypertension. 1998 Jan;31(1):68-72
9449393
Eur J Pharmacol. 1985 Feb 26;109(2):289-92
2987001
Auton Neurosci. 2001 Feb 20;87(1):16-36
11270138
Am J Physiol Renal Physiol. 2006 Oct;291(4):F761-9
16597612
Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R635-44
11448869
Acta Physiol Scand. 1985 Apr;123(4):511-3
3838851
J Biol Chem. 2006 Jul 14;281(28):19709-19
16698801
Neurochem Int. 2008 Dec;53(6-8):338-45
18831999
Am J Physiol Renal Physiol. 2009 Jan;296(1):F98-F106
18945826
Life Sci. 2006 Sep 20;79(17):1585-92
16828490
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H477-85
15458945
Can J Physiol Pharmacol. 2003 Feb;81(2):89-94
12710520
Am J Physiol Renal Physiol. 2006 Dec;291(6):F1184-91
16849693
J Hypertens. 1995 Oct;13(10):1181-91
8586810
Physiol Rev. 1997 Jan;77(1):75-197
9016301
J Vasc Res. 1996 Mar-Apr;33(2):164-74
8630350
Mol Interv. 2003 May;3(3):157-68
14993422
Am J Physiol. 1993 Nov;265(5 Pt 1):C1443-8
8238491
J Hypertens. 1996 Jun;14(6):705-12
8793692
J Cardiovasc Pharmacol. 2001 Oct;38 Suppl 1:S17-20
11811353
J Physiol. 2005 Oct 1;568(Pt 1):315-21
16037092
Circ Res. 2007 Aug 3;101(3):221-3
17673679
Nature. 2000 Jan 6;403(6765):86-9
10638758